Oncopole, a Montreal-based research center, announced that five teams won the Onco-Tech Competition and will receive a total of $1.97 ($2.6 million CAD) in funding. The five winning projects all aim to use advanced technologies, including AI, to improve care for cancer patients.
The Onco-Tech Competition is a joint collaboration between Oncopole, the MEDTEQ Consortium, the TransMedTech Institute and the Cancer Research Society. The contest “is an opportunity for Quebec investigators to accelerate the development, validation and marketing of new medical technologies in oncology, for the benefit of patients,” according to a prepared statement.
The five winning projects are:
- “Better classification of mammographic abnormalities using artificial intelligence”
- “Towards a better quantitative and multiplexed lung cancer diagnosis using metallic nanoparticles”
- “Predicting the clinical response to immunotherapy for lung cancer patients, using artificial intelligence”
- “Better detection of hepatocellular carcinomas to improve the effectiveness of liver cancer treatments using novel algorithms”
- “A predictive platform of radiation treatments using breakthroughs in artificial intelligence”
“This major funding will enable the projects selected to benefit from targeted and complementary expertise to accelerate the development of new medical technologies, providing hope in the fight against cancer,” according to the statement.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.